Investing Now Could Prove Beneficial For VYNE Therapeutics Inc. (NASDAQ: VYNE)

 

Investing Now Could Prove Beneficial For VYNE Therapeutics Inc. (NASDAQ: VYNE)

During the recent session, VYNE Therapeutics Inc. (NASDAQ:VYNE)’s traded shares were 2.18 million, with the beta value of the company hitting 0.72. At the last check today, the stock’s price was $2.19 …

More Investing Now Could Prove Beneficial For VYNE Therapeutics Inc. (NASDAQ: VYNE) Videos

Leave a Reply